Abiopharma

Catalyst Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Catalyst Pharmaceuticals, Inc. - CPRX

TRYNGOLZA® (olezarsen) approved by the FDA as the first and only treatment to reduce triglycerides and the risk of acute pancreatitis in patients with severe hypertriglyceridemia (sHTG)

Events and transactions

Grid Dynamics reunió a los líderes tecnológicos de los mercados de capitales en el XT26 para analizar la volatilidad de la IA en los servicios financieros

Grid Dynamics ha ospitato XT26, riunendo leader del settore tecnologico dei mercati dei capitali sulla volatilità dellAI nei servizi finanziari

Grid Dynamics veranstaltete die XT26 und brachte führende Vertreter der Kapitalmarkttechnologie zusammen, um über die Volatilität der KI im Finanzdienstleistungssektor zu diskutieren

Grid Dynamics organiseerde XT26, een bijeenkomst van toonaangevende spelers op het gebied van kapitaalmarkttechnologie rond het thema de volatiliteit van AI in de financiële dienstverlening

Grid Dynamics a organisé lévénement XT26, qui a réuni les leaders du secteur des technologies des marchés de capitaux autour du thème de la volatilité de lIA dans les services financiers

Organon & Co. Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Organon & Co. - OGN

Apogee Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apogee Therapeutics, Inc. - APGE